Driver KIT mutations in melanoma cluster in four hotspots

Area of Science:

• Oncology
• Molecular Biology
• Dermatology

Background:

• KIT mutations are found in a subset of melanomas.
• While some melanomas with KIT mutations respond to KIT inhibitors, response is not guaranteed.
• Recent data suggest only specific KIT mutations confer sensitivity to KIT inhibitors.

Purpose of the Study:

• To identify which KIT mutations are driver mutations in melanoma.
• To determine the therapeutically relevant KIT mutations for melanoma treatment.

Main Methods:

• Analysis of KIT mutation locations in melanoma.
• Assessment of the oncogenic potential of identified KIT mutations in melanocytes.

Main Results:

• 70% of KIT mutations in melanoma cluster in four hotspots: L576, K642, W557-V560, and D816-A829.
• These specific mutations were confirmed as oncogenic in melanocytes and are bona-fide driver mutations.
• The identified hotspots represent therapeutically targetable mutations.

Conclusions:

• Testing for KIT mutations in melanoma should prioritize the four identified hotspots.
• Targeting these specific KIT hotspots offers a promising therapeutic strategy for melanoma.